Several somatic gene therapies that use an array of viral vectors have shown some promise in correcting hypoglycemia and prevention of HCA in GSD1a animal models19–22 and one of these is currently being evaluated in humans23. This evidence concerns the gene G6PC1 and hepatocellular adenoma.